DoW Alzheimer’s Transforming Diagnosis Award

Summary

The Department of Defense (DoD), through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is soliciting applications for the DoW Alzheimer's Transforming Diagnosis Award. This grant opportunity is focused on advancing Alzheimer's disease diagnosis research and transformation. The opportunity is posted on Grants.gov with a response window spanning from May 2026 to September 2026. Full scope details, eligibility criteria, and technical requirements are not elaborated in the synopsis text provided.

How they evaluate

Risks & flags

• Extremely minimal synopsis — no scope of work, eligibility requirements, evaluation criteria, or funding levels are disclosed, making competitive assessment nearly impossible from this notice alone.
• Award title references a very specific diagnostic transformation focus that may narrow eligibility to specialized Alzheimer's research institutions.